Hi,  welcome to EN-CPhI.cn  Sign In Join Free For Buyer

Search Inquiry Cart (0)
XINHE YUANSHENG MEDICINE CO., LTD.
XINHE YUANSHENG MEDICINE CO., LTD.
You are here: Home >> Marketing Website>> Company Profile
  • Our Company
  • Year Established: 1969

  • Total Annual Sales(USD): choose not to disclose

  • Total Number of Staff: more than 500

  • Main Competitive Advantages:

  • Other Competitive Advantages:

  • Patents and Copyrights:

  • Our Business
  • Business Type: Manufacturer

  • Annual Sales(USD): choose not to disclose

  • Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Asia

  • Major Product Categories: Active Pharmaceutical Ingredients , Intermediates

  • All Products: TRIMEBUTINE MALEATE and its intermediates such as trimebutine base and trimebutine butanol//pheny1-2-Demethyl-Amino-2-Butanol;

  • Product Export Percentage:

  • Product Domestic Sale Percentage:

  • Main Clients' Names:

  • Other Information
  • Contract Manufacturing

  • Payment Terms

Company Profile

Founded in 1969, the initial name was Gushi County Pharmaceutical Factory. Now, it has been turned into one of the subsidiary company of Henan Xinhe Construction and Investment Corporation. The company is engaged in manufacturing Chinese and Western medicinal products and active pharmaceutical ingredient. The registered capital is 84 million RMB and the company now possesses 280 million RMB assets.The registered address is No. 185 East Liaocheng Road, Gushi County, Henan, China, and the postal code is 465200.

Consist of 12 departments and 6 workshops, with 750 employees among which there are 270 technicians with different educational levels.

The company is able to manufacture over 160 kinds of products at 8 dose types including large volume intravenous injection, small volume intravenous injection, tablet, capsule, granule, distillate medicinal water, tincture and API. All the workshops are state GMP approved. Besides, the product ‘trimebutine maleate’ has been successfully registered KDMF in South Korea, Cofepris GMP certificate in Mexico and JDMF in Japan. COS in Europe is in the works.

 

 

API named Trimebutine maleate and tablet made from it are the dominant products. The sales network covers more than 20 provinces at home. Besides, trimebutine maleate has been exporting to some countries or areas of Asia, Europe, South America etc. 

Last Updated: Feb 6, 2018 Add as my favorite supplier Abuse Report Product Alert
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
网页对话
live chat